National Institutes of Health logo
NIH HEAL Initiative

NIH HEAL Initiative — Open NOFOs

Supports opioid, pain, and substance use disorder research in the NIH HEAL portfolio.

OpenNational Institutes of HealthUnited StatesDeep-tech · core fit

The NIH HEAL (Helping to End Addiction Long-term) Initiative is a trans-NIH research portfolio addressing the national opioid overdose and pain management crisis, administered across multiple NIH Institutes and Centers rather than by a single IC. As of May 2026, HEAL has more than 20 active NOFOs with deadlines spanning July 2026 through August 2028, plus approximately 10 forecasted opportunities announced but not yet open. Active solicitations include PAR-25-154 (R03 preclinical pain target discovery, deadline July 16, 2026), PAR-25-051 (UG3/UH3 Blueprint Neurotherapeutics Network small-molecule discovery, August 18, 2026), RFA-AR-27-002 (U24 INTERACT data coordination, October 2, 2026), RFA-AT-25-003 (R15 Pain Research Enhancement Program, November 23, 2026), RFA-NS-25-023 (R61/R33 analgesic discovery, January 15, 2027), and PAR-25-100 (R34 pilot SUD health services research, May 8, 2027).

Research areas funded across the HEAL portfolio span opioid overdose prevention, non-addictive pain management, analgesic drug discovery targeting the understudied druggable proteome, substance use disorder treatment, behavioral health services, and health systems implementation. Individual HEAL NOFOs vary substantially in eligible applicant types: some are open to any domestic research organization including for-profits, nonprofits, and universities, while others are restricted to specific entity classes. Small businesses seeking HEAL funding should focus on NOFOs with SBIR/STTR activity codes or mechanisms compatible with commercial development.

HEAL funding flows through the administering IC for each NOFO (including NINDS, NIDA, NIAMS, NCATS, and others), meaning application review, paylines, and program officer contacts differ by opportunity. Applications are submitted through Grants.gov and reviewed by the relevant IC's study section or advisory council. The HEAL initiative contact for portfolio-level inquiries is healquestion@od.nih.gov. Applicants should subscribe to the NIH Guide for Grants and Contracts for new HEAL NOFO postings and check simpler.grants.gov for forecasted opportunities that will open in the 2026–2028 window.

Opioid overdose prevention, non-addictive pain management, substance use disorder treatment, analgesic drug discovery, and health services research across the NIH HEAL trans-agency portfolio.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.16 Jul 2026
Decision timeiTypical time from the deadline to the funder's decision.
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Last verified: 29 Jun 2026Source: www.nih.gov